Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130206003M |
| Application |
Cardiac Marker |
The kit has been designed for the quantitative determination of Myoglobin in human serum. The method can be used for samples over the range of 0-2,000ng/ml. The test has to be performed on the MAGLUMI chemiluminescence immunoassay (CLIA) fully auto analyzer (Including MAGLUMI 1000, MAGLUMI 2000 and MAGLUMI 2000 Plus and new developed models).
High-Performance Myoglobin TestingWith its rapid assay time of around 18 minutes and high-throughput operation, the MAGLUMI Myoglobin (CLIA) kit allows clinical laboratories to efficiently assess myoglobin levels in patient samples. It leverages magnetic microbead-based CLIA technology, ensuring both sensitivity and accuracy for the reliable detection of myocardial injury or muscle damage.
Reliable and Automated QuantificationDesigned for use with fully automated MAGLUMI analyzers, this kit provides precise, reproducible results with minimal manual intervention. The 2-point calibration system is analyzer-managed, simplifying workflow and enhancing consistency. The kit's components are stable when stored properly, maintaining performance throughout its shelf life.
Simple Sample Handling and Broad CompatibilityAccepting serum or plasma (EDTA, heparin, or citrate) samples, the reagent kit supports flexible integration into standard laboratory processes. It is powered via the analyzer and requires no additional power source. Certified with a CE mark and offering a broad measurement range (5-2000 ng/mL), it serves as a valuable tool in various clinical settings.
FAQ's of Snibe MAGLUMI Myoglobin (CLIA):
Q: How does the Snibe MAGLUMI Myoglobin (CLIA) kit work in quantifying myoglobin?
A: The kit utilizes magnetic microbead-based chemiluminescence immunoassay (CLIA) technology to detect and quantify myoglobin in human serum or plasma samples. After loading the sample onto the analyzer, the system automatically performs all assay steps, providing quantitative results within approximately 18 minutes.
Q: What sample types are compatible with this myoglobin assay?
A: The Snibe MAGLUMI Myoglobin (CLIA) assay accepts serum as well as plasma samples prepared with EDTA, heparin, or citrate anticoagulants, offering versatility for clinical laboratories.
Q: When should myoglobin testing be performed using this kit?
A: Myoglobin testing is typically conducted when there is a suspicion of muscle injury, such as acute myocardial infarction or rhabdomyolysis. The kit allows for rapid results, so testing can be performed promptly in urgent clinical scenarios.
Q: Where is the intended setting for use of the MAGLUMI Myoglobin (CLIA) kit?
A: This kit is intended exclusively for professional use in clinical or hospital laboratories equipped with MAGLUMI CLIA analyzers. It is not designed for point-of-care or portable field use.
Q: What are the benefits of this myoglobin CLIA kit for laboratories?
A: The main benefits include high sensitivity and specificity, a rapid assay time (18 minutes), fully automated processing, and reliable quantitative results. The kit's long shelf life and CE certification further ensure consistent performance.
Q: How should the kit be stored to maintain stability and accuracy?
A: For optimal performance, store the kit unopened at 2-8C and protect it from light. Proper storage ensures reagent stability for up to 12 months from the date of manufacture.
Q: What is the calibration process for the MAGLUMI Myoglobin assay?
A: Calibration is managed automatically by the MAGLUMI analyzer, using a 2-point calibration procedure. This process helps maintain accuracy and simplifies routine operation for laboratory personnel.